statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INmune Bio ( NASDAQ:INMB ) Full Year 2023 Results Key Financial Results Net loss: US$30.0m (loss widened by 9.9% from...

INmune Bio Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Q4 2023 INmune Bio Inc Earnings Call Transcript

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
INMB stock results show that INmune Bio missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of...

INMB Stock Earnings: INmune Bio Misses EPS, Misses Revenue for Q4 2023

INmune Bio, Inc. (INMB) Q4 2023 Earnings Call Transcript...

INmune Bio, Inc. (INMB) Q4 2023 Earnings Call Transcript

Financial Results Align with Analyst Projections Despite Revenue DeclineRelated Stocks: INMB...

INmune Bio Inc (INMB) Posts Year-End Earnings, Reveals Net Loss Amidst Clinical Advancements

Company to Host Conference Call Today, March 28, at 4:30pm ETBOCA RATON, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the Company ), a clinical-stage immunology company...

INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update

This indicator may be signaling that INMB's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

INmune Bio (INMB, $11.66) entered Downtrend as Momentum indicator drops below 0 level on Mar 27, 2024

For the last three days, A.I.dvisor has detected that INMB's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

INmune Bio (INMB, $11.66) Aroon Indicator entered a Downtrend on March 27, 2024.

INmune Bio (INMB, $11.97) Aroon Indicator entered a Downtrend on March 26, 2024.

INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL.

Watchers	3,315
52-Wk Low	$6.50
52-Wk High	$14.74

Volume	75,850.00
52-Wk High	$14.74
52-Wk Low	$6.50

Current Price	$9.19
Prev Close	$9.63
Open	$9.47
Dividend Yield	0.00%
50-Day Moving Average	$10.53
Beta	1.41
Avg. Volume	106,425.59
PE Ratio	-4.79

52-Week High	$14.74
52-Week Low	$6.50
Market Capitalization	$181.8M
EPS	-$1.92
Price to Book	5.68
Revenue Per Employee	$7,705.88
Enterprise Value/EBITDA	-5.64

INMB INmune Bio Inc

About

Feed

News

Sentiment

Earnings

Fundamentals